Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. (2013)

First Author: Babiker AG
Attributed to:  Adult HIV Clinical Trials funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 22547421

Publication URI:

Type: Journal Article/Review

Volume: 10

Parent Publication: Clinical trials (London, England)

Issue: 1 Suppl

ISSN: 1740-7745